In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-15 of 15 for your search:
Drug:  vindesine
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631
2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL01, NCT00198991
3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: Over 15
Sponsor: Other
Protocol IDs: GMALL05, NCT00199082
4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: CDR0000528029, ALL-BFM-2000, EU-20682, NCT00430118
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: CDR0000613220, MOTOL-ALL-IC-BFM-2002, EU-20871, ALL-IC-BFM-2002, NCT00764907
6.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CDR0000633503, GOELAMS-LH2007, GOELAMS-ID-RCB#2007-A01079-44, INCA-RECF0754, AMGEN-GOELAMS-LH2007, NCT00920153
7.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: AIEOP-BFM ALL 2009, NCT01117441
8.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 to 60
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GAINED, NCT01659099
9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 01081, NCT00759824
10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 15 and over
Sponsor: Other
Protocol IDs: NILG 2009-012950-19, NCT01290120
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: EWALL-PH-02, 2010-022855-46, NCT01528085
12.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 6 months to 21
Sponsor: Other
Protocol IDs: GPOH-NB2004-HR, NB2004-HR, UNI-KOELN-161, NCT00526318, EU-20661
13.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000588011, USCTU-IELSG-26-RHM-CAN0546, EU-20818, EudraCT 2006-005794-22, USCTU-07/Q1704/68, IELSG-26-RHM-CAN0546, NCT00689845
14.

Phase: No phase specified
Type: Treatment
Status: Active
Age: Child
Sponsor: Other
Protocol IDs: POWH-CRE-2008.077-T, CRE-2008.077-T, NCT00707083
15.

Phase: No phase specified
Type: Treatment
Status: Active
Age: Under 35
Sponsor: Other
Protocol IDs: LAL1308, GIMEMA-LAL1308, EU-21042, NCT01156883
New Search